vitamin d supplementation in healthy children and adolescents sch journal club rachel harrison 20 th...
TRANSCRIPT
Vitamin D Supplementation in Healthy Children and Adolescents
SCH Journal Club
Rachel Harrison
20th September 2012
Background• Vit D plays an essential role in maintaining good health:
– calcium and phosphate regulation– may regulate cell growth, neuromuscular and immune
function, and reduction of inflammation. • Sunshine!• Vitamin D supplementation agenda since 1990’s• An independent advisory committee is reviewing current
recommendations on vit D (expected 2014)
Background• Vitamin D deficiency serum 25(OH)D level ≤25nmol/l • Insufficiency serum 25(OH)D level between 26 and
50nmol/l
DOH• DOH says the following people may be at risk of vit D
deficiency:– all pregnant and breastfeeding women – all children aged under five years old – all people aged 65 or over – people who are not exposed to much sun – people who have darker skin (because their bodies
are less able to produce as much vit D)
Current Guidelines
• http://www.sheffield.nhs.uk/professionals/resources/Vitamin_D_guidelines_children_Final_March%202012[1].pdf
• Advice – obtain Vit D from safe sun exposure and diet.• Improving availability and uptake of Vit D supplements
for children in multiethnic populations is essential to the strategy of rickets prevention.
• During treatment of deficiency consider referral to secondary care at any stage if new symptoms cause parental or professional concern.
Trust Policy
Available multivitamin preparations Product Vitamin D content Dose Other considerations
Healthy Start Drops (10ml).
Multivitamin preparation
Colecalciferol – 300IU per 5 drops
300IU / dose (5 drops) Free from soya and peanut residues
Dalivit (25ml or 50ml bottles).
Multivitamin preparation Licensed product.
Ergocalciferol 400 IU per 0.6 mL
6 weeks- 1year –200IU - 0.3ml (7drops) daily
≥ 1 year 400IU = 0.6ml = 14 drops daily
Can be added to squash, juice, milk or jam for ease of administration.
Does not contain peanut oil or soya
Abidec (25ml) Multivitamin preparationLicensed product
Ergocalciferol 400 IU per 0.6 mL,
Birth -1year -200units – 0.3ml (7drops) daily
≥ 1 year 400iu = 0.6ml = 14 drops daily
Contains peanut oil. Contraindicated in patients with a peanut allergy. Also avoid in patients with a soya allergy.
Adcal D3 chewable tablets / caplets
Contains calcium and Vitamin D
Chewable tablets -Colecalciferol 400IU /tablet (and 600mg Calcium)
Caplets –colecalciferol 200IU/caplet (and 300mg Calcium)
Chewable tablets – One daily (only licensed in children above 12 years)
Caplets – Two daily (only licensed in children above 12 years)
Please note the difference strengths between the chewable tablets and the caplets
Contains soya oil in the chewable tablets. Refer to SPC for full list of excipients.
The Clinical Question
Population Healthy children and adolescents
Intervention Vitamin D supplementation
Comparison Placebo
Outcome Bone Density
Study Design Systematic Review
Effects of Vitamin D supplementation on bone density in healthy children: a
systematic review
Winzenberg,T. Powell, S. Shaw, K A. Jones, G.
BMJ. 2011;342:c7254.
Objectives• To determine effectiveness of Vitamin D supplementation
for improving BMD in children and adolescents• To determine if effects of supplementation vary with
factors such as vitamin D dose and status
Methods• Systematic review and meta-analysis• RCT’s of vitamin D supplementation including a placebo
control• Children and adolescents aged 1 month to <20 years• Identification of papers
– Databases – Conference abstracts– Cited references
Methods• Extracted data by 2 reviewers• Percent change in baseline of bone outcomes• Standardised mean difference• Hetrogeneity• Fixed effects model
Outcomes• BMD – spine, radius, hip• BMC – total body• Subgroup analysis
– Age– Gender– Pubertal stage– Vitamin D dose– Vitamin D status
Results – Papers Reviewed
1653 papers identified1599 excluded
54 disagreements6 German papers
23 full text review
4 not RCTs3 children not 1/12 to <20 yr
2 not bone outcomes1 not Vit D intervention1 not placebo controlled
6 studies included in meta analysis
1 no variance measured reported
12 papers for 7 studies
Results – Baseline Characteristics
Event Title If Required (Change Text in Footer)
Results – Main Effects
Event Title If Required (Change Text in Footer)
Results – Forrest Plot
Event Title If Required (Change Text in Footer)
Results – Vit D Status
Are the results of the review valid?• Did the review address a clearly focused question?
Yes – Clear population, intervention, and outcome
• Did the authors look for the appropriate sort of papers?
Yes – RCT’s placebo controlled
Is it worth continuing?• Do you think the important, relevant studies were included?
Yes – appropriate databases searched, no language restrictions, reference lists of cited studies searched, conference abstracts
• Did the review’s authors do enough to assess the quality of the included studies?
Yes – independently assessed by 2 reviewers
• If the results of the review have been combined, was it reasonable to do so?
Yes – Similar studies, similar outcomes
What are the results?• What are the overall results of the reviews?
LS BMD 0.15 (-0.01 to 0.31; p=0.07) standardised mean difference
Supplementation not beneficial in children and adolescents with normal Vit D levels
In deficient children may be useful, but needs confirmation
• How precise are the results?
Not sure – Confidence intervals reported, standardised mean difference
Will the results help locally?• Can the results be applied to the local population?
Yes - children 8-17 yrs
• Were all important outcomes considered?
Not sure – main outcome covered
• Are the benefits worth the harms and costs?
No
Summary and Conclusions• Overall a good paper• Publication of negative results• Clear bottom line reported
• For clinicians and other health professionals:
No action to be take. What this space.